Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Oppenheimer

SpaceX Is the World’s Most Ambitious Company. You Should Still Wait for a Pullback in SPCX Stock Before You Buy.

SpaceX receives a price hike from Oppenheimer analyst citing Cursor acquisition and AI stack advantage.

Barchart

Dear Walmart Stock Fans, Mark Your Calendars for June 22

Walmart Deals returns June 22 through June 28 with thousands of offers on electronics, fashion, toys, and more. Here is what shoppers need to know.

Barchart

Elon Musk Heartbreak: SpaceX Stock Officially Drops Into The Low $170s Just Days After Wall Street Debut

SpaceX shares have tumbled into the low $170s just days after Elon Musk's company made its high‑profile Wall Street debut, wiping out most of its early gains.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Grok Could Be a Reason to Stay Away from the SpaceX IPO

Grok usage dipping might be a warning sign for SpaceX.

Barchart

Oppenheimer Initiates Coverage on SpaceX With an ‘Outperform’ Rating. How Spacex Stock Could Be a Literal Financial Rocket Ship.

The firm has a price target of $190 for the hottest IPO around.

Barchart

SPCX Stock Alert: Here's What Analysts Are Saying Ahead of the SpaceX IPO

Oppenheimer and New Street Research initiated coverage on SpaceX stock with a bullish stance on Thursday. Here’s what their analysts told clients in their research notes today.

Barchart

US stocks: Oppenheimer launches Wall Street's first coverage of SpaceX with bullish outlook

Brokerage Oppenheimer has started covering SpaceX. They issued an 'outperform' rating and set a price target of $190. This is ahead of the rocket and AI company's market debut. Oppenheimer sees SpaceX as a unique AI company. Starlink is expected to be a major cash generator. SpaceX's AI business will…

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

Oracle Earnings Could Reveal a Massive $100 Billion Spending Surge. Here Is Why You Should Still Buy ORCL Stock.

BNP Paribas expects Oracle to increase its capital spending in the June 10 earnings report.

Barchart

Can Elon Musk do to US telecom what Mukesh Ambani did in India?

Elon Musk's Starlink is poised to disrupt American telecom giants like AT&T and Verizon. Analysts believe Starlink could change how connectivity is delivered and who controls it. SpaceX's satellite internet service is evolving into a mainstream platform. This shift could accelerate declines in subscriber growth and revenue for traditional operators.

The Economic Times

Sterling Infrastructure Stock Pops as Investors Flock to the Next Wave of AI Data Center Investment

Sterling Infrastructure popped on June 3, as investors piled on construction firms tied to AI buildouts.

Barchart

Why the SpaceX IPO Is Sending AT&T Stock Down Today

Oppenheimer just downgraded AT&T stock to “Perform,” citing incoming SpaceX competition. Find out more.

Barchart

Christopher Nolan to be honoured with major retrospective as The Odyssey frenzy builds

The Toronto International Film Festival will celebrate Christopher Nolan’s complete filmography this summer with special 35mm and 70mm screenings ahead of the release of his much-anticipated epic The Odyssey.

BANG Premier

Palo Alto Networks Just Got a New Street-High Price Target. Analysts Are Betting Big on PANW Stock Before June 2.

Ahead of its Q3 results on June 2, Palo Alto Networks is enjoying bullish analyst sentiments.

Barchart

Palo Alto Networks Up 70%: Can the Rally Last Into June?

Palo Alto Networks looks dangerously overbought, but the fundamental momentum and pre-earnings setup mean the bulls mightn't be wrong to stay in.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

NVDA Stock Watch: What to Expect as Jensen Huang Joins Trump-Xi Summit

Nvidia stock rallies as Jensen Huang joins Trump on a high-stakes visit to China. Oppenheimer explains why NVDA shares are poised to rip higher from here in 2026.

MarketBeat

EnerSys Touts AI Data Center and Defense ‘Super Cycles’ at Oppenheimer Conference

Enersys (NYSE:ENS) management outlined the company’s growth priorities in data centers, defense, warehousing and energy storage during a discussion at Oppenheimer’s 21st Annual Industrial Growth Conference, emphasizing what President and CEO Shawn O’Connell described as exposure to two major “super

Barchart

Ahead of Airbnb Earnings, Here Is What Barchart Options Data Shows for ABNB Stock

Airbnb is set to report its fiscal Q1 earnings tomorrow (May 7) after market close. Options traders are currently positioned for upside in ABNB stock after its quarterly release.

Barchart

What Are Wall Street Analysts' Target Price for U.S. Bancorp Stock?

Despite outperforming the broader market over the past year, U.S. Bancorp continues to draw a measured but optimistic outlook from Wall Street analysts.

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger

S&P 500 Hits New High on Apple Earnings: Stock Market Today

Apple rounded out a big week of mega-cap earnings on a high note, sending two of the three main equity indexes to new highs on Friday.

Barchart

Amazon Just Signed a Major Deal to Supply Its In-House Chips to Meta Platforms. AMZN Stock Now Has Multiple AI Chip Catalysts.

With demand surging, Amazon is moving beyond cloud into AI chips, and its growing silicon push is opening multiple new growth catalysts.

The Guardian - AU

Michael moonwalks to $217m opening weekend, shattering box office records for a biopic

Michael Jackson biopic has shrugged off controversy, bad reviews and a troubled production to take $217m worldwide, including $97m in North America

Barchart

Marvell Stock Just Got a New Street-High Price Target. Should You Buy Shares Here?

Oppenheimer has grown more bullish on Marvell as AI demand and growth projections strengthen. Does this justify buying at current levels?

Barchart

Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?

Revolution Medicines stock rallies on impressive daraxonrasib Phase 3 results. Here’s why RVMD shares may sustain the momentum moving forward.

Barchart

Why Oppenheimer Is Betting on Monolithic Power Stock Alongside Nvidia and Marvell Here

Oppenheimer sees Monolithic Power benefiting from AI demand, with long-cycle opportunities to translate into sustained upside.

Barchart

Netflix Just Admitted It Needs More Money. Is That a Red Flag for NFLX Stock?

In order to pay for its content budget, Netflix will be hiking subscription prices. Is that a red flag for investors or just part of a normal growth plan?

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations